Published in Lancet on July 04, 1998
Systemic therapies for inflammatory eye disease: past, present and future. BMC Ophthalmol (2013) 1.12
Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye (Lond) (2011) 1.10
Emerging drugs for uveitis. Expert Opin Emerg Drugs (2011) 1.08
Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol (2006) 1.02
Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. Clin Ophthalmol (2013) 1.02
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol (2005) 1.00
[Uveitis in conjunction with rheumatological diseases in childhood]. Ophthalmologe (2005) 0.96
Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. Int Ophthalmol (2008) 0.94
A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology (2014) 0.88
Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation. Br J Ophthalmol (2005) 0.88
Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series. Int Ophthalmol (2009) 0.86
Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.82
Pharmacokinetics, electrophysiological, and morphological effects of the intravitreal injection of mycophenolic acid in rabbits. J Ocul Pharmacol Ther (2014) 0.80
Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium. Br J Ophthalmol (1999) 0.78
Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach. Clin Pulm Med (2016) 0.76
Diagnostic techniques for inflammatory eye disease: past, present and future: a review. BMC Ophthalmol (2013) 0.76
Pseudotumor cerebri following cyclosporine A treatment in a boy with tubulointerstitial nephritis associated with uveitis. Pediatr Nephrol (2004) 0.75
Recurring paralysis. BMJ Case Rep (2009) 0.75
Mycophenolate mofetil therapy in uveitis: analysis of eight cases in a tertiary ophthalmic care centre in India. Int Ophthalmol (2007) 0.75
Reduced mortality compared with national averages following phacoemulsification cataract surgery: a retrospective observational study. Br J Ophthalmol (2008) 2.13
Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol (2000) 2.10
Clinical investigation of a true color scanning laser ophthalmoscope. Arch Ophthalmol (2001) 2.07
A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med (2003) 1.72
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology (1980) 1.67
Orientation and directed migration of cultured corneal epithelial cells in small electric fields are serum dependent. J Cell Sci (1996) 1.58
Acute intraoperative suprachoroidal haemorrhage in ocular surgery. Eye (Lond) (1998) 1.55
The corneoscleral limbus in human corneal epithelial wound healing. Am J Ophthalmol (1990) 1.54
Urokinase in the treatment of vitreous haemorrhage. Lancet (1972) 1.51
An image-processing strategy for the segmentation and quantification of microaneurysms in fluorescein angiograms of the ocular fundus. Comput Biomed Res (1996) 1.47
Quantitative image analysis of macular drusen from fundus photographs and scanning laser ophthalmoscope images. Eye (Lond) (1995) 1.45
Low power vs standard power transpupillary thermotherapy in patients with age-related macular degeneration and subfoveal choroidal neovascularization ineligible for photodynamic therapy. Eye (Lond) (2005) 1.43
Cell subpopulations in failed human corneal grafts. Br J Ophthalmol (1999) 1.41
Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis? Eye (Lond) (1997) 1.41
Quantification of diabetic maculopathy by digital imaging of the fundus. Eye (Lond) (1991) 1.40
The minim technique for diagnostic anterior chamber paracentesis. Eye (Lond) (2008) 1.38
Sympathetic ophthalmia risk following vitrectomy: should we counsel patients? Br J Ophthalmol (2000) 1.38
Adhesion of neutrophil leucocytes under conditions of flow. J Cell Sci (1984) 1.35
Clinical investigation of an infrared digital scanning laser ophthalmoscope. Br J Ophthalmol (1994) 1.35
A small, physiological electric field orients cell division. Proc Natl Acad Sci U S A (1999) 1.34
Electric field-directed cell motility involves up-regulated expression and asymmetric redistribution of the epidermal growth factor receptors and is enhanced by fibronectin and laminin. Mol Biol Cell (1999) 1.29
Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol (1996) 1.27
The pathology and pathogenesis of retinal vasculitis. Neuropathol Appl Neurobiol (2003) 1.25
Directed migration of corneal epithelial sheets in physiological electric fields. Invest Ophthalmol Vis Sci (1996) 1.23
Neural progenitor cells from postmortem adult human retina. Br J Ophthalmol (2005) 1.22
Adhesion of cells to polystyrene surfaces. J Cell Biol (1983) 1.21
Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol (1993) 1.21
Fundal white dots: the spectrum of a similar pathological process. Br J Ophthalmol (1995) 1.20
Evaluation of corneal graft rejection in a mouse model. Br J Ophthalmol (2002) 1.20
Ultrastructural pathology of S-antigen uveoretinitis. Invest Ophthalmol Vis Sci (1985) 1.17
Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol (1998) 1.17
Human corneal epithelial cells reorient and migrate cathodally in a small applied electric field. Curr Eye Res (1997) 1.17
Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia (1997) 1.17
Clinical patterns of corneal epithelial wound healing. Am J Ophthalmol (1987) 1.17
A comparison of computer based classification methods applied to the detection of microaneurysms in ophthalmic fluorescein angiograms. Comput Biol Med (1998) 1.16
Digital fundus imaging using a scanning laser ophthalmoscope. Physiol Meas (1993) 1.16
Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology (1990) 1.15
Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2001) 1.14
Campath-1H therapy in refractory ocular inflammatory disease. Br J Ophthalmol (2000) 1.13
Automated detection and quantification of microaneurysms in fluorescein angiograms. Graefes Arch Clin Exp Ophthalmol (1992) 1.13
Automated detection of microaneurysms in digital red-free photographs: a diabetic retinopathy screening tool. Diabet Med (2000) 1.13
Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci (1999) 1.13
A fully automated comparative microaneurysm digital detection system. Eye (Lond) (1997) 1.12
The scanning laser ophthalmoscope--a review of its role in bioscience and medicine. Phys Med Biol (2004) 1.12
Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci (1981) 1.11
Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology (1994) 1.10
Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye (Lond) (2011) 1.10
Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia. Br J Ophthalmol (1995) 1.09
Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. J Immunol (1997) 1.09
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol (2009) 1.09
Clinical experience with interferon alfa-2a for exudative age-related macular degeneration. Br J Ophthalmol (1993) 1.08
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A. Br J Ophthalmol (1997) 1.08
The treatment of chronic uveitic macular oedema. Br J Ophthalmol (1994) 1.07
Retinal antigen specific lymphocytes, TCR-gamma delta T cells and CD5+ B cells cultured from the vitreous in acute sympathetic ophthalmitis. Autoimmunity (1993) 1.07
Histology of the lacrimal gland in keratoconjunctivitis sicca. Br J Ophthalmol (1973) 1.07
Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Clin Exp Immunol (1988) 1.06
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H. Br J Ophthalmol (1995) 1.06
Bilateral serous macular detachment as a presenting feature of acute lymphoblastic leukemia. Eur J Ophthalmol (2005) 1.05
Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye (Lond) (1994) 1.04
Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol (1998) 1.04
Recurrent septic retinal emboli following dental surgery. Br J Ophthalmol (1996) 1.04
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med (2005) 1.02
Chemokinetic accumulation of human neutrophils on immune complex-coated substrata: analysis at a boundary. J Cell Biol (1984) 1.02
Fundus autofluorescence in the diagnosis of cystoid macular oedema. Br J Ophthalmol (2008) 1.02
Fundus imaging in patients with cataract: role for a variable wavelength scanning laser ophthalmoscope. Br J Ophthalmol (1995) 1.01
Distribution of OX2 antigen and OX2 receptor within retina. Invest Ophthalmol Vis Sci (2001) 1.00
Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol (2001) 1.00
CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1 alpha. J Immunol (2000) 1.00
Lytic therapy in vitreous haemorrhage. Trans Ophthalmol Soc U K (1974) 1.00
Quality of life and visual function in patients with intermediate uveitis. Br J Ophthalmol (2005) 1.00
Intravitreal fibrinolysis in experimental vitreous haemorrhage. Exp Eye Res (1976) 0.99
Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye (Lond) (1990) 0.99
Performance measurements of an infrared digital scanning laser ophthalmoscope. Physiol Meas (1994) 0.98
Properties of porcine and recombinant human collagen matrices for optically clear tissue engineering applications. Biomacromolecules (2006) 0.98
Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol (1998) 0.97
Control of chemokine production at the blood-retina barrier. Immunology (2000) 0.97
IFN-gamma and LPS-mediated IL-10-dependent suppression of retinal microglial activation. Invest Ophthalmol Vis Sci (2000) 0.97
Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol (1993) 0.97
Nestin positive cells in adult human retina and in epiretinal membranes. Br J Ophthalmol (2003) 0.96
Management of the dry eye in Sjogren's syndrome. Br J Ophthalmol (1974) 0.96
Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis. Gene Ther (2008) 0.96
TGF-beta and IL-1 beta act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells. Immunology (1995) 0.96
Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome. Br J Ophthalmol (2000) 0.96
Nuclear magnetic resonance tomography of the orbit at 3.4 MHz. Br J Radiol (1985) 0.96
The value of digital imaging in diabetic retinopathy. Health Technol Assess (2003) 0.95
Steroid induced glaucoma: a report of two cases with a review of morbidity and prescribing in general practice. Scott Med J (1990) 0.95
Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Ocul Immunol Inflamm (1998) 0.95
Imaging of optic nerve head drusen with the scanning laser ophthalmoscope. Br J Ophthalmol (1997) 0.95
Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat Nanotechnol (2011) 0.94